Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,473–1,480 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Dermata Therapeutics Inc. Xyngari(TM) (DMT310) - (STAR-1) Moderate-to-severe acne Phase 3 Data Released Topical #N/A
Dermata Therapeutics Inc. Xyngari(TM) (DMT310) Rosacea Phase 2 Topical N/A
Dermata Therapeutics Inc. DMT410 Axillary Hyperhidrosis Phase 2a Trial Planned Intralesional N/A
DiaMedica Therapeutics Inc. DM199 (rinvecalinase alfa) Preeclampsia (PE) Phase 2 Trial Planned Intravenous Women's Health
DiaMedica Therapeutics Inc. Rinvecalinase Alfa (DM199) - (ReMEDy2) Acute ischaemic stroke (AIS) Phase 2/3 Ongoing Intravenous Neurology
DiaMedica Therapeutics Inc. DM199 - (REDUX) Chronic Kidney Disease Phase 2 Trial Completed Intravenous N/A
Dianthus Therapeutics Inc Com MGTA-145 and plerixafor Sickle Cell Disease Phase 2 Trial Discontinued Subcutaneous injection Hematology
Dianthus Therapeutics Inc. Claseprubart - (MaGic) Generalized Myasthenia Gravis (gMG) Phase 2 Data Released Oral Neurology